News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
750,133 Results
Type
Article (44317)
Company Profile (468)
Press Release (705332)
Multimedia
Podcasts (147)
Webinars (23)
Section
Business (209573)
Career Advice (2050)
Deals (36248)
Drug Delivery (141)
Drug Development (84189)
Employer Resources (174)
FDA (16818)
Job Trends (15238)
News (354792)
Policy (33307)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2693)
Accelerated approval (56)
ADA (49)
Adcomms (31)
Allergies (188)
Alliances (51118)
ALS (230)
Alzheimer's disease (1882)
Antibody-drug conjugate (ADC) (525)
Approvals (17218)
Artificial intelligence (739)
ASCO (337)
Autoimmune disease (343)
Automation (58)
Bankruptcy (374)
Best Places to Work (11840)
BIOSECURE Act (20)
Biosimilars (233)
Biotechnology (325)
Bladder cancer (205)
Brain cancer (78)
Breast cancer (805)
Cancer (6331)
Cardiovascular disease (514)
Career advice (1745)
Career pathing (46)
CAR-T (364)
CDC (59)
Celiac Disease (3)
Cell therapy (988)
Cervical cancer (52)
Clinical research (73229)
Collaboration (2264)
Company closure (5)
Compensation (1490)
Complete response letters (94)
COVID-19 (2815)
CRISPR (121)
C-suite (1242)
Cystic fibrosis (164)
Data (8580)
Decentralized trials (3)
Denatured (46)
Depression (179)
Dermatology (96)
Diabetes (660)
Diagnostics (7069)
Digital health (63)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (361)
Drug pricing (213)
Drug shortages (32)
Duchenne muscular dystrophy (315)
Earnings (93494)
Editorial (70)
Employer branding (21)
Employer resources (153)
Events (124225)
Executive appointments (1145)
FDA (20758)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (19)
Frontotemporal dementia (36)
Funding (1880)
Gene editing (260)
Generative AI (62)
Gene therapy (799)
GLP-1 (1139)
Government (4848)
Grass and pollen (6)
Guidances (416)
Healthcare (19479)
Hematology (194)
HIV (88)
Huntington's disease (60)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (114)
Immunology and inflammation (325)
Immuno-oncology (111)
Indications (206)
Infectious disease (3181)
Inflammatory bowel disease (231)
Inflation Reduction Act (17)
Influenza (140)
Intellectual property (317)
Interviews (320)
IPO (16966)
IRA (53)
Job creations (3721)
Job search strategy (1443)
JPM (67)
Kidney cancer (20)
Labor market (109)
Layoffs (604)
Leadership (43)
Legal (8032)
Liver cancer (105)
Longevity (35)
Lung cancer (843)
Lymphoma (465)
Machine learning (62)
Management (59)
Manufacturing (1127)
MASH (214)
Medical device (14127)
Medtech (14280)
Mergers & acquisitions (20569)
Metabolic disorders (1684)
mRNA (248)
Multiple sclerosis (199)
NASH (20)
Neurodegenerative disease (475)
Neuropsychiatric disorders (115)
Neuroscience (3548)
Neurotech (1)
NextGen: Class of 2026 (6775)
Non-profit (4612)
Now hiring (79)
Obesity (791)
Opinion (316)
Ovarian cancer (238)
Pain (270)
Pancreatic cancer (343)
Parkinson's disease (404)
Partnered (34)
Patents (626)
Patient recruitment (747)
Peanut (66)
People (61259)
Pharmaceutical (80)
Pharmacy benefit managers (34)
Phase 1 (23035)
Phase 2 (32314)
Phase 3 (23859)
Pipeline (9594)
Policy (342)
Postmarket research (2607)
Preclinical (9881)
Press Release (67)
Prostate cancer (338)
Psychedelics (64)
Radiopharmaceuticals (364)
Rare diseases (1203)
Real estate (6084)
Recruiting (71)
Regulatory (26186)
Reports (56)
Research institute (2519)
Resumes & cover letters (356)
Rett syndrome (42)
RNA editing (28)
RSV (88)
Schizophrenia (189)
Series A (318)
Series B (235)
Service/supplier (11)
Sickle cell disease (126)
Special edition (29)
Spinal muscular atrophy (172)
Sponsored (49)
Startups (3840)
State (2)
Stomach cancer (19)
Supply chain (135)
Tariffs (88)
The Weekly (98)
Vaccines (1161)
Venture capital (125)
Weight loss (515)
Women's health (137)
Worklife (21)
Date
Today (31)
Last 7 days (618)
Last 30 days (2916)
Last 365 days (31184)
2026 (15395)
2025 (31056)
2024 (36286)
2023 (41011)
2022 (52276)
2021 (56759)
2020 (54917)
2019 (47413)
2018 (35693)
2017 (33022)
2016 (32346)
2015 (38395)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (760)
Alabama (99)
Alaska (7)
Arizona (370)
Arkansas (16)
Asia (41360)
Australia (6887)
California (14047)
Canada (3916)
China (1507)
Colorado (604)
Connecticut (625)
Delaware (428)
Europe (91041)
Florida (2076)
Georgia (446)
Hawaii (3)
Idaho (63)
Illinois (1148)
India (94)
Indiana (628)
Iowa (25)
Japan (582)
Kansas (136)
Kentucky (53)
Louisiana (59)
Maine (76)
Maryland (1669)
Massachusetts (10178)
Michigan (375)
Minnesota (759)
Mississippi (6)
Missouri (149)
Montana (35)
Nebraska (29)
Nevada (146)
New Hampshire (89)
New Jersey (3689)
New Mexico (33)
New York (3653)
North Carolina (1833)
North Dakota (10)
Northern California (7067)
Ohio (418)
Oklahoma (23)
Oregon (44)
Pennsylvania (2780)
Puerto Rico (29)
Rhode Island (52)
South America (1126)
South Carolina (86)
South Dakota (2)
Southern California (5532)
Tennessee (221)
Texas (2237)
United States (49656)
Utah (413)
Vermont (1)
Virginia (340)
Washington D.C. (82)
Washington State (1146)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
750,133 Results for "vyome therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vyome Holdings Reports First Quarter 2026 Results With Key FDA Filings and Strong Balance Sheet
May 28, 2026
·
7 min read
Press Releases
Vyome Presents Transformational VT-1953 Phase 2 Clinical Study Data at Prestigious AACR 2026
April 23, 2026
·
6 min read
Press Releases
Vyome to Present Compelling Phase 2 Clinical Data on VT-1953 for Treatment of MFW at AACR 2026
April 6, 2026
·
4 min read
Press Releases
Vyome Announces the Publication of Positive Preclinical Results in Uveitis, Addressing a $3B Potential Market Opportunity
February 18, 2026
·
6 min read
Press Releases
Vyome Successfully Capitalizes All VT-1953 Funding Requirements For Initial Phase 3 Results
February 2, 2026
·
4 min read
Press Releases
Vyome Files for VT-1953 Orphan Drug Status, Furthers Strategic Focus On VT-1953 Program Over the Next 6 Months
February 11, 2026
·
5 min read
Press Releases
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics
August 8, 2025
·
3 min read
Press Releases
Vyome Holdings Announces Transformational First Quarter Following Nasdaq Listing
November 19, 2025
·
7 min read
Press Releases
Vyome Reports Positive Final Phase 2 Results for VT-1953; Plans to Advance Into Pivotal Study For FDA Approval
December 9, 2025
·
6 min read
Press Releases
Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow
August 15, 2025
·
3 min read
1 of 75,014
Next
